In the colitis-associated cancer mouse model, colonic chitinase 3-like 1 (CHI3 L1) can bind to RAGE, and thus disrupt the S100A9-associated expression positive feedback loop during early immune activation, creating a S100A9 low colonic environment, especially in the later phase of colitis. Here, CHI3L1 is linked to cancer.